Diabetic murine models for Acinetobacter baumannii infection. - Wikidata - wikimedia - TriplyDB

Diabetic murine models for Acinetobacter baumannii infection.

Diabetic murine models for Acinetobacter baumannii infection.

http://www.wikidata.org/entity/Q43237805

about

Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii.Bacteriological and resistance profile in isolates from diabetic patients Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model.Validation of a novel murine wound model of Acinetobacter baumannii infection.Establishment of Experimental Murine Peritonitis Model with Hog Gastric Mucin for Carbapenem-Resistant Gram-Negative Bacteria.Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE.Mouse Models of Acinetobacter baumannii Infection.A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.Expression of Toll-like receptor 4 in lungs of immune-suppressed rat with Acinetobacter baumannii infection Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence.The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.Expression pattern of soluble triggering receptor expressed on myeloid cells-1 in mice with Acinetobacter baumannii colonization and infection in the lung.

P2860

Q36405521-37641FEE-0BE9-4222-9AD0-943148599E7D Q36415338-D92F671A-0BB9-4AB4-AD30-939D69808236 Q36457770-4CB4E969-7748-4998-93F6-49E3D7B9494A Q36888042-28DC3E99-99FA-4483-A667-E2E4B97EF055 Q37643643-76A48882-291F-4B52-B197-3E09231994A7 Q37739009-E422D795-7171-4882-9B5A-61654E5EC49D Q39038590-6A1F3F6D-7AC9-4F11-ADC3-FC093AEB3B60 Q39265442-D70B69BB-7DE0-4F02-A705-2AFCD836672C Q40083827-F39654C9-1F18-4349-865B-A41F7D4492E9 Q40097164-5A207375-068B-4F97-9722-899B119D412F Q40131084-603F0DC8-4F64-4667-AD84-D3AEA7E8E269 Q40516975-556EC7F1-6F98-4CC4-BE34-3ACEC2560A49 Q41138033-85535BE4-9EC1-49F5-9C8B-801DA2F5BB5D Q54215616-1562F494-9810-4DFA-B569-C0DE5BA8F08F Q55296015-4E7D6CF6-30FF-4DCC-8FDC-AD0E5D030C98

P2860

Diabetic murine models for Acinetobacter baumannii infection.

http://www.wikidata.org/entity/Q43237805

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Diabetic murine models for Acinetobacter baumannii infection.

@en

Diabetic murine models for Acinetobacter baumannii infection.

@nl

type

label

Diabetic murine models for Acinetobacter baumannii infection.

@en

Diabetic murine models for Acinetobacter baumannii infection.

@nl

prefLabel

Diabetic murine models for Acinetobacter baumannii infection.

@en

Diabetic murine models for Acinetobacter baumannii infection.

@nl

P1433

Q43237805-2A2364C2-B8F5-40A4-B28D-1A86B05E85F7

P1476

Q43237805-22FA59D1-BCED-44C5-B77C-AAED3F4E26A6

P2093

Q43237805-08146FF6-6587-4893-89E6-00247578D617

Q43237805-42E6D210-F4DF-4221-8B6A-893C3A3CADD9

Q43237805-5B80911E-54D9-40C4-ACD6-03AE95ED12C0

Q43237805-8502CF8D-73D5-4727-95F8-73AFADDD9C9B

Q43237805-95E490D5-886A-490C-AC9B-C931904F9E3C

Q43237805-BEF3E6A3-B067-40F0-A5AC-539810671E57

Q43237805-C786F1A9-551A-4D89-ADE7-F1B0C587C969

Q43237805-E8856065-FC03-4CF9-9D06-9EC4D954D181

P2860

Q43237805-006A91FE-945D-43DF-8BF1-B333F4C044E9

Q43237805-042640C3-BECD-4896-A6F3-198D1EDAA38C

Q43237805-0E1AB520-8C5D-43E3-81CF-5E8D76F4032D

Q43237805-194AF999-0135-43A3-AD01-52A5BEB0DC17

Q43237805-20D8D22A-3DD2-4CB9-B2F0-9CBDF6F8BF03

Q43237805-2DD4C96A-C1E0-4F52-9B3A-AA45FB30B8DA

Q43237805-320E6C8C-D179-42E2-B484-959091B00CC6

Q43237805-32ED82A1-8962-4BC8-BDF1-DCD60D66BF76

Q43237805-39F342C1-3498-4FB3-871A-DBED6FE22FBE

Q43237805-41C2E39E-C18D-46AB-912F-FFF1CBBFA551

P304

Q43237805-F4DCEB47-1B3D-489D-88E7-D69637AEEF03

P31

Q43237805-B07DD53A-7242-4956-BA2A-0D1F86073ADF

P356

Q43237805-C13D783C-0800-4594-A284-00C3E926427D

P407

Q43237805-19979C7B-7AE4-4982-A2A4-E35985BDB3E9

P433

Q43237805-A5DE983A-E271-4694-B3AE-2A999122296B

P478

Q43237805-D819B389-F270-49BE-91D3-C34DB0982822

P577

Q43237805-76C2A454-ED65-41B9-9635-4D91E9203BFF

P5875

Q43237805-29369A09-2F22-4DF2-BC8E-B375AE0B4524

P698

Q43237805-95EE279C-D6D8-4542-8311-9260E35C482B

P921

Q43237805-32E544F6-B20F-4B6D-AEC4-1191486CBD6F

P932

Q43237805-36FD5EAD-37B1-4C52-8D99-B9A0E0FAE8FA

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Diabetic murine models for Acinetobacter baumannii infection.

@en

P2093

Ashraf S Ibrahim

http://www.w3.org/2001/XMLSchema#string

Brad Spellberg

http://www.w3.org/2001/XMLSchema#string

Guanpingsheng Luo

http://www.w3.org/2001/XMLSchema#string

Hongkyu Lee

http://www.w3.org/2001/XMLSchema#string

Michael Bolaris

http://www.w3.org/2001/XMLSchema#string

Samuel W French

http://www.w3.org/2001/XMLSchema#string

Teclegiorgis Gebremariam

http://www.w3.org/2001/XMLSchema#string

Yue Fu

http://www.w3.org/2001/XMLSchema#string

P2860

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.

The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.

The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii.

Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus.

Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.

P304

1439-1445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKS050

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221887189

http://www.w3.org/2001/XMLSchema#string

P698

22389456

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

P932

3584961

http://www.w3.org/2001/XMLSchema#string